| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Issuance of common stock and warrants in connection with the sales agreement, net of issuance costs | - | 0 |
| Net issuance costs in connection with the sales agreement | - | 28 |
| Net proceeds from issuance of common stock in connection with the sales agreement, net of issuance costs | -28 | - |
| Net cash provided by financing activities | 2,683 | -265 |
| Effect of exchange rate changes on cash and cash equivalents | 93 | 33 |
| Net decrease increase in cash, cash equivalents and restricted cash | -15,724 | -11,558 |
| Cash and cash equivalents at beginning of period | 19,690 | - |
| Cash and cash equivalents at end of period | 3,966 | - |
Vivani Medical, Inc. (VANI)
Vivani Medical, Inc. (VANI)